The Hiv Treatment Cascade in People Living With Hiv in Iran in 2014: Mixed-Method Study to Measure Losses and Reasons Publisher Pubmed



Ghalehkhani N¹ ; Farhoudi B² ; Gouya MM³ ; Sharifi H¹ ; Seyedalinaghi S⁴ ; Kamali K⁵ ; Fahimfar N⁵ ; Rajabpour Z⁵ ; Doostiirani A⁶ ; Sedaghat A⁷ ; Mirzazadeh A^{1, 8} Show Affiliations
Source: International Journal of STD and AIDS Published:2019

Abstract

The study assessed the HIV treatment cascade of people living with HIV (PLWH) in Iran and the reasons for gaps in HIV services in 2014. We did the cascade analysis using the WHO HIV test–treat–retain cascade analysis tool (2014). To measure the gaps, we checked the records for all PLWH reported to the national HIV surveillance till September 2014 to define how many were alive, linked to HIV care, assessed for CD4 cell count, started antiretroviral therapy (ART), and reported to be alive up to five years after ART. To assess the reasons for gaps in the cascade, we ran desk review, four focus group discussions and 51 in-depth interviews with key informants including PLWH. Spectrum model estimated 75,700 PLWH in Iran, of whom only 22,647 people (%30) were diagnosed. Of those who were diagnosed with HIV, 16,266 people (%72) had enrolled in HIV care. About 13% of all PLWH were retained in HIV care and only 9% (6745 people) had ever been tested for CD4 cell count. Only 8% (6018 people) of all PLWH had received ART by September 2014. We found the biggest gap in the HIV treatment cascade to be HIV diagnosis as only 30% of PLWH have been diagnosed. Innovative strategies to improve HIV testing, particularly those that work best for key populations, are critical to reach the 90–90-90 targets. © The Author(s) 2019.